Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...

Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...

Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.

Eli Lilly faces market headwinds, slowing growth, and rising competition. Discover why now might be the time for LLY ...

Not many companies that have been around since the late 1800s can claim that they're growth companies. Eli Lilly's stock is ...

The current Wall Street consensus one-year price target of Lilly stock is $951.98, which is 17.7% higher than today’s price. Of the 29 analysts covering Lilly stock, all but six recommend buying ...

Eli Lilly stock (NYSE: LLY) stock is showing positive momentum on Thursday, April 17th, ... Eli Lilly and has a price-to-sales (P/S) ratio of 16.6 vs. a figure of 2.8 for the S&P 500; ...

Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference. Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year. The ...

Explore Eli Lilly analyst ratings and price targets (NYSE:LLY) on Benzinga. Stay updated on expert opinions and forecasts for LLY stock.

Eli Lilly has a price-to-sales (P/S) ratio of 16.6 versus 2.8 for the S&P 500; It trades at a price-to-earnings (P/E) ratio of 70 compared to 22 for the S&P 500 ...